Drug

BR1015 clinical trials

Also written BR1015.

studies test it: 10
open now: 4
in phase 3: 0
first study started: 2023

Keep track of what changes. Save the BR1015 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

BR1015-A: 4

Development codes

BR1015: 6

Studies by the year they started

10 studies that test it; most in 2025 (4)

Studies that test BR1015, by start year
Year	Studies
2023	2
2025	4
2026	4

By phase

A phase 1/2 study counts in both.

Phase 1: 10

What it is tested for

Each study’s main condition, where its own words name it.

Essential Hypertension: 8
Hypertension: 2

Who runs them

Industry 10 · Other 0

Boryung Pharmaceutical Co., Ltd (10)

Studies

Open first, then newest update. How each study uses BR1015 is read from its arms, and is right about nine times in ten.

Testing it · 10

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421388Written as BR1015-A
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421401Written as BR1015-A
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421375Written as BR1015-A
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421414Written as BR1015-A
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744127Written as BR1015
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744062Written as BR1015
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744426Written as BR1015
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744439Written as BR1015
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06008028Written as BR1015
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06008015Written as BR1015